
QICC
The premier international conference on interventional cardiology, bringing together world leaders in cardiovascular innovation.
Visit congress websiteQICC Media center connects QICC, QICC-BTS and CHINA VALVE — bringing together clinical practice, basic and translational science, and heart valve innovation. Explore congress highlights, expert perspectives and research updates from our cardiovascular community.
Chairman's Message

The premier international conference on interventional cardiology, bringing together world leaders in cardiovascular innovation.
Visit congress website
Dedicated to advances in basic and translational cardiovascular science, uniting global experts and pioneers.
Visit congress website
Advancing heart valve research, technology and clinical practice in China.
Visit congress website
Live from CHINA VALVE (HANGZHOU) 2026: Prof. Jian’an Wang’s team presents multiple high-level procedures in a global live broadcast.

Bring your research and submission questions for a one-on-one consultation with the JACC editorial team.

QICC-BTS 2026: rooted deep in basic science, surging toward the frontiers of translation.

Academician Jian’an Wang’s team presented the SINGLE-CLOSURE study results at TCT 2026, with the article published simultaneously in JACC.

Landmark findings from Prof. Xinyang Hu and Prof. Yang Xu’s team at the Second Affiliated Hospital, Zhejiang University School of Medicine: heart failure therapy enters a new era of immune-targeted treatment.

Academician Jian’an Wang’s team at the Second Affiliated Hospital, Zhejiang University School of Medicine wins Second Prize of the State Science and Technology Progress Award.
Academician Jian’an Wang and his team from the Second Affiliated Hospital, Zhejiang University School of Medicine share the latest SINGLE-CLOSURE study at TCT 2026.
Read story
The JACC: Asia Center Program launches its first stop in Hangzhou, bringing more Asian cardiovascular research to the world’s attention.
Read storyOn April 8, Beijing time, research on engineered dendritic cells inducing immune tolerance to improve cardiac remodeling in heart failure was published in Nature.
Read story
Returning to the heart of medicine — bringing cardiovascular innovations to the people.
Read storyProf. Martin Leon reflects on what defines true medical innovation and where the next generation of interventional cardiologists should head.
Read storyProf. William F. Fearon discusses the past and present of coronary intervention, and the next step for physiology-guided precision PCI.
Read storyJoin the 20th Qianjiang Cardiovascular Conference, November 19–22, 2026.